drugset / Trial / NCT00958451

Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients

NCT00958451

RandomizedParallel-groupOpen-labelTreatment

Summary

This is an open label, single center, randomized, active comparator controlled study, comparing the effects of vitamin D replacement using oral ergocalciferol versus paricalcitol on parathyroid hormone (PTH) levels in patients with stage 3 and 4 CKD and vitamin D deficiency or insufficiency. The purpose of this study is to determine which of these two approaches is more successful.

Timeline

Start
2009-07
Primary completion
2011-01
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ergocalciferol Small molecule 50000 iu Oral
Comparator Paricalcitol Other / unclassified 1 ug Oral
Comparator Paricalcitol Other / unclassified 2 ug Oral